Wedbush Securities Inc. Increases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wedbush Securities Inc. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 6,582 shares of the exchange traded fund’s stock after purchasing an additional 405 shares during the quarter. Wedbush Securities Inc.’s holdings in SPDR S&P Biotech ETF were worth $593,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Addison Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 27.4% in the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after acquiring an additional 115 shares during the period. Invst LLC boosted its stake in shares of SPDR S&P Biotech ETF by 6.0% during the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after purchasing an additional 160 shares in the last quarter. Beech Hill Advisors Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 2.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock valued at $599,000 after purchasing an additional 162 shares in the last quarter. Wealth Alliance raised its stake in SPDR S&P Biotech ETF by 4.4% in the fourth quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after buying an additional 173 shares in the last quarter. Finally, CX Institutional raised its stake in SPDR S&P Biotech ETF by 1.6% in the fourth quarter. CX Institutional now owns 12,196 shares of the exchange traded fund’s stock worth $1,098,000 after buying an additional 196 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $69.80 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $68.88 and a fifty-two week high of $105.47. The stock’s 50 day simple moving average is $86.82 and its two-hundred day simple moving average is $92.53. The stock has a market cap of $4.40 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were given a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.